Outlook Therapeutics Inc
OTLK
Market Cap$78.85M
Close$
$-0.80
142.7% downside
Current Fair Value
142.7% downsideOvervalued by 142.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $78.85 Million |
|---|---|
| Enterprise Value | $4.20 Trillion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-9.84 |
| Beta | 0.39 |
| Outstanding Shares | 30,874,396 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 24666730.45 |
| Enterprise Value to EBIT | -0.04 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 2.8 |
| Debt to Equity | -0.36 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Outlook Therapeutics Inc
8 employees
CEO: Lawrence Kenyon